| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer
1 company
Komjathy Andrew serves as a Chief Commercial Officer at ATXS. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $670 at current prices.
The biggest single holding is ATXS (~$670) as Chief Commercial Officer. Net of sales, the recent Form 4 record there shows accumulation of 100 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2021 | ATXS Astria Therapeutics, Inc. | Chief Commercial Officer | Buy | 100 | $6.70 | $669.50 | New | -3.5% | +32.7% |